CaroGen Competitors and Similar CompaniesClear all
CaroGen's competitors and similar companies include Immatics and Prosetta.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | |||
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Farmington, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations San Francisco, US HQ |
Employees | Employees 12 | Employees 29723% increase | Employees 254% increase |
Funding | |||
Latest funding round | Latest funding round $ 1.4m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 2m (about 19 years ago) |
Total funding raised | Total funding raised $ 1.6m | Total funding raised $ 267.3m | Total funding raised $ 2m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company
Prosetta
HQ
San Francisco, US
Employees
25↑ 4% increase
Prosetta Corporation operates as a biopharmaceutical company in the United States.
View company